Research-grade reagents for Chikungunya virus (CHIKV) — a mosquito-borne alphavirus causing debilitating polyarthralgia. E1/E2 envelope glycoproteins are key neutralization and vaccine targets. We offer recombinant/polyclonal/InVivoMAb antibodies, recombinant proteins, validated for ELISA, WB, IHC, FCM, IF, Neutralization. RUO
All products manufactured by AtaGenix Laboratories under ISO 9001 & ISO 13485 quality systems.
Chikungunya virus (CHIKV)
ELISA, IF, WB
Human
IgG1, kappa
5F10
Mammalian cells
AIL00833.1
Ser326-Gln666
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Chikungunya virus (CHIKV)
Mammalian cells
Q8JUX5
Tyr810-Lys1221
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Chikungunya virus (CHIKV)
Chikungunya virus (CHIKV)
ELISA
Human
VHH-Fc
Nb-A9
Chikungunya virus (CHIKV)
ELISA
Human
IgG1, kappa
C37
Chikungunya virus (CHIKV)
ELISA
Human
IgM, kappa
5F10
Chikungunya virus (CHIKV)
ELISA
Human
IgA, kappa
5F10
Chikungunya virus (CHIKV)
ELISA, Neutralization
Human
IgG1
m242
Chikungunya virus (CHIKV), Mayaro virus (MAYV), Ross River virus (RRV), O'nyong'nyong virus (ONNV), Semliki Forest virus (SFV)
ELISA, FCM, Neutralization
Human
IgG1, kappa
CHK265
Chikungunya virus (CHIKV)
ELISA
Human
IgG1, kappa
5M16